Immediate versus staged complete myocardial revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: A post hoc analysis of the randomized FLOWER-MI trial.

Fiche publication

Date publication

septembre 2022

Journal

Archives of cardiovascular diseases

Auteurs

Membres identifiés du Cancéropôle Est :
Pr COTTIN Yves

Tous les auteurs :
Tea V, Morelle JF, Gallet R, Cayla G, Lemesle G, Lhermusier T, Dillinger JG, Ducrocq G, Angouvant D, Cottin Y, Chamandi C, le Bras A, Steg PG, Montalescot G, Nelson AC, Simon T, Chatellier G, Danchin N, Puymirat E,

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/36096979

Résumé

In patients with ST-segment elevation myocardial infarction and multivessel disease, percutaneous coronary intervention for non-culprit lesions is superior to treatment of the culprit lesion alone. The optimal timing for non-infarct-related artery revascularization - immediate versus staged - has not been investigated adequately.